Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume 41, Issue 10, Pages 1133-1148
Publisher
Wiley
Online
2011-04-18
DOI
10.1111/j.1365-2362.2011.02520.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma
- (2014) Luis Syro et al. Hormones-International Journal of Endocrinology and Metabolism
- A Rare Case of Aplastic Anemia Caused by Temozolomide
- (2011) Benjamin J. George et al. SOUTHERN MEDICAL JOURNAL
- Dose-dense temozolomide regimens
- (2010) Bart Neyns et al. CANCER
- MGMT Immunoexpression in Silent Subtype 3 Pituitary Adenomas: Possible Therapeutic Implications
- (2010) Michael E. Fealey et al. ENDOCRINE PATHOLOGY
- Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
- (2010) Marco Losa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
- (2010) Zachary M. Bush et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide-induced inhibition of pituitary adenoma cells
- (2010) Jason Sheehan et al. JOURNAL OF NEUROSURGERY
- Predicting the myelotoxicity of chemotherapy
- (2010) Ami Sabharwal et al. MELANOMA RESEARCH
- O-Methylguanine-DNA Methyltransferase Immunoexpression in a Double Pituitary Adenoma
- (2010) Safraz Mohammed et al. NEUROSURGERY
- MGMT immunoexpression in aggressive pituitary adenoma and carcinoma
- (2010) Queenie Lau et al. Pituitary
- Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap due to Oral Temozolomide and Cranial Radiotherapy
- (2009) Nilendu Sarma AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- O6-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas
- (2009) Georg Widhalm et al. CANCER
- Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma
- (2009) C. K. Augustine et al. CLINICAL CANCER RESEARCH
- Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
- (2009) Alberto Fernandez et al. CLINICAL ENDOCRINOLOGY
- High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease
- (2009) Akira Takeshita et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
- (2009) C Hagen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Hypersensitivity pneumonitis associated with temozolomide
- (2009) L. Guilleminault et al. EUROPEAN RESPIRATORY JOURNAL
- Long-term use of temozolomide: Could you use temozolomide safely for life in gliomas?
- (2009) Mustafa Khasraw et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
- (2009) Jennifer A. Quinn et al. JOURNAL OF CLINICAL ONCOLOGY
- USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS
- (2009) Safraz Mohammed et al. NEUROSURGERY
- Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults
- (2008) S. Kesari et al. CLINICAL CANCER RESEARCH
- O6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors
- (2008) M. H. Kulke et al. CLINICAL CANCER RESEARCH
- Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
- (2008) Ann I. McCormack et al. CLINICAL ENDOCRINOLOGY
- Treatment of Nelson's syndrome with temozolomide
- (2008) V J Moyes et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Non-Hodgkin's Lymphoma in Patients With Glioma Treated With Temozolomide
- (2008) Bart Neyns et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Extended-Dose Temozolomide in Patients With Melanoma
- (2008) Petra Rietschel et al. JOURNAL OF CLINICAL ONCOLOGY
- New (alternative) temozolomide regimens for the treatment of glioma
- (2008) Wolfgang Wick et al. NEURO-ONCOLOGY
- Management of aggressive pituitary adenomas: current treatment strategies
- (2008) Michael Buchfelder Pituitary
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started